OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ROYS54

Royal Sense Ltd

Medical Equipment, Supplies & DistributionVerified

Royal Sense Ltd's capital structure is characterized by a lack of dilution risk, as shares outstanding for both basic and diluted scenarios are identical at 5,350,146. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for Royal Sense Ltd, as no valuation snapshot or industry_config preferred metrics have been provided. This limits the ability to compare the company's performance against industry medians or to assess its financial health in relation to peers. Segment and geographic exposure details are not disclosed in the available data, making it impossible to evaluate revenue concentration or geographic diversification. The company's exposure to specific markets or product lines remains opaque. Growth trajectory is also indeterminate, as no outlook data or revenue history is available. Without numeric deltas or directional guidance for the current or next fiscal year, it is not possible to assess the company's growth potential or performance trends. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The absence of balance-sheet data and going-concern language in source documents raises concerns about the company's financial stability. Recent events, including filings or transcripts, are not disclosed in the available data. This limits the ability to evaluate the company's recent performance or strategic direction based on public disclosures.

30-day price · ROYS+9.20 (+7.0%)
Low$128.00High$198.00Close$140.00As of17 May, 00:00 UTC
Profile
CompanyRoyal Sense Ltd
TickerROYS.BO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Royal Sense Ltd provides medical equipment, supplies, and distribution services within the healthcare sector.

Classification. Royal Sense Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Royal Sense Ltd's capital structure is characterized by a lack of dilution risk, as shares outstanding for both basic and diluted scenarios are identical at 5,350,146. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for Royal Sense Ltd, as no valuation snapshot or industry_config preferred metrics have been provided. This limits the ability to compare the company's performance against industry medians or to assess its financial health in relation to peers. Segment and geographic exposure details are not disclosed in the available data, making it impossible to evaluate revenue concentration or geographic diversification. The company's exposure to specific markets or product lines remains opaque. Growth trajectory is also indeterminate, as no outlook data or revenue history is available. Without numeric deltas or directional guidance for the current or next fiscal year, it is not possible to assess the company's growth potential or performance trends. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The absence of balance-sheet data and going-concern language in source documents raises concerns about the company's financial stability. Recent events, including filings or transcripts, are not disclosed in the available data. This limits the ability to evaluate the company's recent performance or strategic direction based on public disclosures.
Key takeaways
  • Royal Sense Ltd operates in the medical equipment and supplies distribution segment of the healthcare industry.
  • The company shows no dilution risk, as basic and diluted shares are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet data and lack of going-concern language.
  • Profitability, returns, and growth metrics are not available for comparison with industry benchmarks.
  • Segment and geographic exposure details are not disclosed, limiting visibility into revenue concentration.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3
FY-2$0.00
FY-1$178.0M$22.6M$15.9M$15.6M
FY0$617.3M$88.7M$63.3M$47.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2
FY-1$207.7M$182.2M
FY0$355.6M$277.4M
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1-$38.7M-$335.0k$15.6M
FY0$12.1M-$16.2M$47.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$8.7M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6$207.7M$182.2M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6-$38.7M-$335.0k$8.7M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricROYSActivity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 01:42 UTC#ee2dd5ae
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 06:13 UTCJob: 14f897c0